- Home
- PTCT vs IFS Comparison
PTCT vs IFS Comparison
Compare PTCT & IFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTCT
- IFS
- Stock Information
- Founded
- PTCT 1998
- IFS 1897
- Country
- PTCT United States
- IFS Peru
- Employees
- PTCT N/A
- IFS N/A
- Industry
- PTCT Biotechnology: Pharmaceutical Preparations
- IFS Commercial Banks
- Sector
- PTCT Health Care
- IFS Finance
- Exchange
- PTCT Nasdaq
- IFS Nasdaq
- Market Cap
- PTCT 4.1B
- IFS 4.2B
- IPO Year
- PTCT 2013
- IFS 2019
- Fundamental
- Price
- PTCT $50.57
- IFS $40.09
- Analyst Decision
- PTCT Buy
- IFS Buy
- Analyst Count
- PTCT 14
- IFS 1
- Target Price
- PTCT $67.14
- IFS $30.00
- AVG Volume (30 Days)
- PTCT 1.5M
- IFS 227.1K
- Earning Date
- PTCT 08-07-2025
- IFS 08-11-2025
- Dividend Yield
- PTCT N/A
- IFS 2.37%
- EPS Growth
- PTCT N/A
- IFS 112.04
- EPS
- PTCT 7.72
- IFS 4.72
- Revenue
- PTCT $1,764,929,000.00
- IFS $1,492,951,578.00
- Revenue This Year
- PTCT $119.89
- IFS N/A
- Revenue Next Year
- PTCT N/A
- IFS $8.71
- P/E Ratio
- PTCT $6.55
- IFS $8.29
- Revenue Growth
- PTCT 96.00
- IFS 34.92
- 52 Week Low
- PTCT $30.41
- IFS $23.53
- 52 Week High
- PTCT $58.38
- IFS $40.25
- Technical
- Relative Strength Index (RSI)
- PTCT 56.09
- IFS 69.65
- Support Level
- PTCT $48.09
- IFS $38.00
- Resistance Level
- PTCT $54.24
- IFS $39.33
- Average True Range (ATR)
- PTCT 2.37
- IFS 0.87
- MACD
- PTCT 0.19
- IFS 0.18
- Stochastic Oscillator
- PTCT 66.83
- IFS 96.30
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
About IFS Intercorp Financial Services Inc.
Intercorp Financial Services Inc is a provider of banking, insurance, wealth management services and payments for retail customers and commercial clients in Peru. The company has four operating segments; the Banking segment includes Mainly loans, credit facilities, deposits, and current accounts, the Insurance segment provides life annuity products with single-premium payment and conventional life insurance products and other retail insurance products, the Wealth Management segment provides brokerage and investment management services. Its geographical segments include Peru and Panama.